Cryo-EM structure of the 2019-nCoV spike in the prefusion conformation

Cited by (1,048)

Items 801–900 of 1,048

1. COVID-19 and Heart Failure: From Epidemiology During the Pandemic to Myocardial Injury, Myocarditis, and Heart Failure Sequelae
   Leonardo Italia, Daniela Tomasoni, Stefano Bisegna, Edoardo Pancaldi, Lorenzo Stretti, Marianna Adamo, Marco Metra · 2021 · Frontiers in Cardiovascular Medicine
2. D614G mutation of SARS-CoV-2 spike protein enhances viral infectivity
   Jie Hu, Changlong He, Qingzhu Gao, Guiji Zhang, Xiaoxia Cao, Quanxin Long, Haijun Deng, Luyi Huang, Juan Chen, Kai Wang et al. · 2020 · bioRxiv (Cold Spring Harbor Laboratory)
3. N-terminal domain antigenic mapping reveals a site of vulnerability for SARS-CoV-2
   McCallum, Matthew, Marco, Anna De, Lempp, Florian, Tortorici, M. Alejandra, Pinto, Dora, Walls, Alexandra C., Beltramello, Martina, Chen, Alex, Liu, Zhuoming, Zatta, Fabrizia et al. · 2021
4. Management of patients with liver derangement during the COVID-19 pandemic: an Asia-Pacific position statement
   Grace Lai‐Hung Wong, Vincent Wai‐Sun Wong, Alexander J. V. Thompson, Jidong Jia, Jinlin Hou, Cosmas Rinaldi Adithya Lesmana, Adityo Susilo, Yasuhito Tanaka, Wah‐Kheong Chan, Ed J. Gane et al. · 2020 · The Lancet. Gastroenterology & hepatology
5. Understanding neutralising antibodies against SARS-CoV-2 and their implications in clinical practice
   Natalie Yan‐Lin Pang, Alexander Shao‐Rong Pang, Vincent T. K. Chow, De Yun Wang · 2021 · Military Medical Research
6. COVID-19 Diagnosis: A Comprehensive Review of the RT-qPCR Method for Detection of SARS-CoV-2
   Debashis Dutta, Sarah Naiyer, Sabanaz Mansuri, Neeraj Soni, Vandana Singh, Khalid Hussain Bhat, Nishant Singh, Gunjan Arora, Mohammad Shahid Mansuri · 2022 · Diagnostics
7. Potential role of ACE2 in coronavirus disease 2019 (COVID-19) prevention and management
   Mengyuan Liu, Ting Wang, Yun Zhou, Yutong Zhao, Yan Zhang, Jianping Li · 2020 · Journal of Translational Internal Medicine
8. A highly specific and sensitive serological assay detects SARS-CoV-2 antibody levels in COVID-19 patients that correlate with neutralization
   David Peterhoff, Vivian Glück, Matthias Vogel, Philipp Schuster, Anja Schütz, Philip Neubert, Veruschka Albert, Stefanie Frisch, Mara Kießling, Philip Pervan et al. · 2020 · Infection
9. Toward Rapid and Sensitive Detection of SARS-CoV-2 with Functionalized Magnetic Nanoparticles
   Jing Zhong, Enja Laureen Rösch, Thilo Viereck, Meinhard Schilling, Frank Ludwig · 2021 · ACS Sensors
10. A single intranasal dose of chimpanzee adenovirus-vectored vaccine protects against SARS-CoV-2 infection in rhesus macaques
    Ahmed O. Hassan, F. Feldmann, Hai-Yan Zhao, D. Curiel, A. Okumura, Tsing-Lee Tang-Huau, J. Case, Kimberly Meade-White, Julie A. Callison, Rita E. Chen et al. · 2021 · Cell Reports Medicine
11. Does SARS-CoV-2 Bind to Human ACE2 More Strongly Than Does SARS-CoV?
    Hoang Linh Nguyen, Pham Dang Lan, Nguyen Quoc Thai, Daniel Allen Nissley, Edward P. O’Brien, Mai Suan Li · 2020 · The Journal of Physical Chemistry B
12. Computational molecular docking and virtual screening revealed promising SARS-CoV-2 drugs
    Maryam Hosseini, Wanqiu Chen, Daliao Xiao, Charles Wang · 2021 · Precision Clinical Medicine
13. A broadly cross-reactive antibody neutralizes and protects against sarbecovirus challenge in mice
    David R. Martinez, Alexandra Schäfer, S. Gobeil, Dapeng Li, Gabriela De la Cruz, Robert Parks, Xiaozhi Lu, Maggie Barr, Victoria Stalls, Katarzyna Janowska et al. · 2021 · Science Translational Medicine
14. Scientific rationale for developing potent RBD-based vaccines targeting COVID-19
    H. Kleanthous, J. Silverman, K. Makar, I. Yoon, Nicholas A. C. Jackson, D. Vaughn · 2021 · npj Vaccines
15. ACE2 and COVID-19 and the resulting ARDS
    Xiaoqing Zhang, Shuren Li, Shaoqian Niu · 2020 · Postgraduate Medical Journal
16. ACE2 (Angiotensin-Converting Enzyme 2), COVID-19, and ACE Inhibitor and Ang II (Angiotensin II) Receptor Blocker Use During the Pandemic
    Andrew Michael South, Tammy McLoughlin Brady, Joseph T. Flynn · 2020 · Hypertension
17. The scRNA-seq Expression Profiling of the Receptor ACE2 and the Cellular Protease TMPRSS2 Reveals Human Organs Susceptible to SARS-CoV-2 Infection
    Jing Qi, Yang Zhou, Jiao Hua, Liying Zhang, Jialin Bian, Beibei Liu, Zicen Zhao, Shuilin Jin · 2021 · International Journal of Environmental Research and Public Health
18. ACE2: the molecular doorway to SARS-CoV-2
    Miriam Marlene Medina-Enríquez, Sandra López‐León, José Alberto Carlos-Escalante, Zuleika Aponte Torres, Angélica Cuapio, Talía Wegman-Ostrosky · 2020 · Cell & Bioscience
19. The rapid diagnosis and effective inhibition of coronavirus using spike antibody attached gold nanoparticles
    Avijit Pramanik, Ye Gao, Shamily Patibandla, Dipanwita Mitra, Martin G. McCandless, Lauren A. Fassero, Kalein Gates, Ritesh Tandon, Paresh Chandra Ray · 2021 · Nanoscale Advances
20. The SARS-CoV-2 spike reversibly samples an open-trimer conformation exposing novel epitopes
    Shawn M. Costello, Sophie R. Shoemaker, Helen T. Hobbs, Annalee W. Nguyen, Ching‐Lin Hsieh, Jennifer A. Maynard, Jason S. McLellan, John E. Pak, Susan Marqusee · 2022 · Nature Structural & Molecular Biology
21. Structural basis for the recognition of the 2019-nCoV by human ACE2
    Renhong Yan, Yuanyuan Zhang, Yingying Guo, Lu Xia, Qiang Zhou · 2020 · bioRxiv (Cold Spring Harbor Laboratory)
22. Two Things about COVID-19 Might Need Attention
    Xiaodong Jia, Chengliang Yin, Shanshan Lu, Yan Chen, Qingyan Liu, Junfan Bai, Yinying Lu · 2020 · Preprints.org
23. Safety and immunogenicity of the SARS-CoV-2 BNT162b1 mRNA vaccine in younger and older Chinese adults: a randomized, placebo-controlled, double-blind phase 1 study
    Li, Jingxin, Hui, Aimin, Zhang, Xiang, Yang, Yumei, Tang, Rong, Ye, Huayue, Ji, Ruiru, Lin, Mei, Zhu, Zhongkui, Türeci, Özlem et al. · 2021 · Nature Medicine
24. Mutations in SARS-CoV-2 viral RNA identified in Eastern India: Possible implications for the ongoing outbreak in India and impact on viral structure and host susceptibility
    Arindam Maitra, Mamta Chawla‐Sarkar, Harsha Raheja, Nidhan K. Biswas, Sohini Chakraborti, Animesh Kumar Singh, Shekhar Ghosh, Sumanta Sarkar, Subrata Patra, Rahul Mondal et al. · 2020 · Journal of Biosciences
25. Spectrum of Neurological Manifestations in Covid-19: A Review
    Ravindra Kumar Garg · 2020 · Neurology India
26. Facile biosensors for rapid detection of COVID-19
    Lizhou Xu, Danyang Li, Sami Ramadan, Yanbin Li, N. Klein · 2020 · Biosensors and Bioelectronics
27. Single-Dose Intranasal Administration of AdCOVID Elicits Systemic and Mucosal Immunity against SARS-CoV-2 and Fully Protects Mice from Lethal Challenge
    Rodney Glenn King, Aarón Silva-Sánchez, Jessica N. Peel, Davide Botta, Alexandria M. Dickson, Amelia K. Pinto, Selene Meza‐Perez, S. Rameeza Allie, Michael D. Schultz, Mingyong Liu et al. · 2021 · Vaccines
28. Two Different Antibody-Dependent Enhancement (ADE) Risks for SARS-CoV-2 Antibodies
    Darrell O. Ricke · 2021 · Frontiers in Immunology
29. SARS-CoV-2 Neutralizing Antibodies for COVID-19 Prevention and Treatment
    Dapeng Li, Gregory D. Sempowski, Kevin O. Saunders, Priyamvada Acharya, Barton F. Haynes · 2021 · Annual Review of Medicine
30. Neurological complications and infection mechanism of SARS-CoV-2
    Dandan Wan, Tingfu Du, Weiqi Hong, Li Chen, Haiying Que, Shuaiyao Lu, Xiaozhong Peng · 2021 · Signal Transduction and Targeted Therapy
31. Antibody-mediated broad sarbecovirus neutralization through ACE2 molecular mimicry
    Young‐Jun Park, Anna De Marco, Tyler N. Starr, Zhuoming Liu, Dora Pinto, Alexandra C. Walls, Fabrizia Zatta, Samantha K. Zepeda, John E. Bowen, Kaitlin R. Sprouse et al. · 2022 · Science
32. Cell surface SARS-CoV-2 nucleocapsid protein modulates innate and adaptive immunity
    Alberto Domingo López-Muñoz, Ivan Košík, Jaroslav Hollý, Jonathan Wilson Yewdell · 2022 · Science Advances
33. Distinct viral clades of SARS‐CoV‐2: Implications for modeling of viral spread
    Adam Brufsky · 2020 · Journal of Medical Virology
34. Comprehensive analysis of drugs to treat SARS‑CoV‑2 infection: Mechanistic insights into current COVID‑19 therapies (Review)
    George Mihai Nițulescu, Horia Păunescu, Sterghios Athanasios Moschos, Dimitrios Petrakis, Georgiana Nițulescu, Daniel Ion, Demetrios A. Spandidos, Τaxiarchis Κonstantinos Νikolouzakis, Nikolaos Drakoulis, Aristidis Michael Tsatsakis · 2020 · International Journal of Molecular Medicine
35. Identification of bioactive compounds from Glycyrrhiza glabra as possible inhibitor of SARS-CoV-2 spike glycoprotein and non-structural protein-15: a pharmacoinformatics study
    Saurabh Kumar Sinha, Satyendra Kuldip Prasad, Md Ataul Islam, Shailendra Shivaji Gurav, Rajesh B. Patil, Nora A. AlFaris, Tahany Saleh Aldayel, Nora M. AlKehayez, Saikh Mohammad Wabaidur, Anshul Shakya · 2020 · Journal of Biomolecular Structure and Dynamics
36. The Role of Type I Interferons in the Pathogenesis and Treatment of COVID-19
    Gideon Schreiber · 2020 · Frontiers in Immunology
37. Computational epitope map of SARS-CoV-2 spike protein
    Mateusz Sikora, Sören von Bülow, Florian E.C. Blanc, Michael Gecht, Roberto Covino, Gerhard Hummer · 2021 · PLoS Computational Biology
38. Systematic analysis of SARS-CoV-2 infection of an ACE2-negative human airway cell
    Maritza Puray‐Chavez, Kyle M. LaPak, Travis Parke Schrank, Jennifer L. Elliott, Dhaval P. Bhatt, Megan J. Agajanian, Ria Jasuja, Dana Q. Lawson, Keanu Davis, Paul W. Rothlauf et al. · 2021 · Cell Reports
39. Identifying infectiousness of SARS-CoV-2 by ultra-sensitive SnS2 SERS biosensors with capillary effect
    Yusi Peng, Chenglong Lin, Yanyan Li, Yong Gao, Jing Wang, Jun He, Zhengren Huang, Jianjun Liu, Xiaoying Luo, Yong Ping Yang · 2021 · Matter
40. L-arginine metabolism as pivotal interface of mutual host–microbe interactions in the gut
    Björn Nüse, Tim Holland, Manfred Rauh, Roman G. Gerlach, Jochen Mattner · 2023 · Gut Microbes
41. Pathophysiological characteristics and therapeutic approaches for pulmonary injury and cardiovascular complications of coronavirus disease 2019
    Yong‐Jian Geng, Zhi-Yao Wei, Hai‐Yan Qian, Ji Huang, Robert F. Lodato, Richard J. Castriotta · 2020 · Cardiovascular Pathology
42. Potential therapeutic targets for combating SARS-CoV-2: Drug repurposing, clinical trials and recent advancements
    Abhjieet Pandey, Ajinkya Nitin Nikam, Ajjappla Basavaraj Shreya, Sadhana P. Mutalik, Divya Gopalan, Sanjay Kulkarni, Bharath Singh Padya, Gasper J. Fernandes, Srinivas Mutalik, Ruth Prassl · 2020 · Life Sciences
43. COVID-19: Review on latest available drugs and therapies against SARS-CoV-2. Coagulation and inflammation cross-talking
    Giuseppe Magro · 2020 · Virus Research
44. COVID‐19 and cutaneous manifestations: a systematic review
    Qing Shan Zhao, Xiaokai Fang, Zheng Pang, Bowen Zhang, Hong Liu, Furen Zhang · 2020 · Journal of the European Academy of Dermatology and Venereology
45. Expression of ACE2 in Human Neurons Supports the Neuro-Invasive Potential of COVID-19 Virus
    Jiaxi Xu, Eric D. Lazartigues · 2020 · Cellular and Molecular Neurobiology
46. Validation and clinical evaluation of a SARS-CoV-2 surrogate virus neutralisation test (sVNT)
    Benjamin Meyer, Johan H J Reimerink, Giulia Torriani, Fion Brouwer, Gert-Jan Godeke, Sabine Yerly, Marieke N. Hoogerwerf, Nicolas Vuilleumier, Laurent Kaiser, Isabella Eckerle et al. · 2020 · Emerging Microbes & Infections
47. COVID-19 Pandemic: Epidemiology, Etiology, Conventional and Non-Conventional Therapies
    Abdur Rauf, Tareq Abu‐Izneid, Ahmed Olatunde, Anees Ahmed Khalil, Fahad Abdulrahman Alhumaydhi, Tabussam Tufail, Mohammad Ali Shariati, Максим Борисович Ребезов, Zainab M. Almarhoon, Yahia N. Mabkhot et al. · 2020 · International Journal of Environmental Research and Public Health
48. The D614G mutations in the SARS-CoV-2 spike protein: Implications for viral infectivity, disease severity and vaccine design
    Danielle C. Groves, Sarah Rowland‐Jones, Adrienn Angyal · 2020 · Biochemical and Biophysical Research Communications
49. Proteolytic Activation of SARS-CoV-2 Spike at the S1/S2 Boundary: Potential Role of Proteases beyond Furin
    Tiffany Tang, Javier A. Jaimes, Miya K. Bidon, Marco R. Straus, Susan Daniel, Gary R. Whittaker · 2021 · ACS Infectious Diseases
50. Epidemiology and pathobiology of SARS-CoV-2 (COVID-19) in comparison with SARS, MERS: An updated overview of current knowledge and future perspectives
    Balasubramanian Ganesh, Thangarasu Rajakumar, Malathi Mathiyazhakan, Manikandan Natesan, Nagaraj Jaganathasamy, Santhakumar Aridoss, Elangovan Arumugam, Yashpal Singh Malik · 2021 · Clinical Epidemiology and Global Health
51. Establishment of a well-characterized SARS-CoV-2 lentiviral pseudovirus neutralization assay using 293T cells with stable expression of ACE2 and TMPRSS2
    S. Neerukonda, R. Vassell, Rachel Herrup, Shu-Feng Liu, Tony T. Wang, K. Takeda, Ye Yang, Tsai-Lien Lin, Wei Wang, C. Weiss · 2020 · bioRxiv
52. An Intranasal OMV-Based Vaccine Induces High Mucosal and Systemic Protecting Immunity Against a SARS-CoV-2 Infection
    Peter van der Ley, Afshin Zariri, Elly van Riet, Dinja Oosterhoff, Corine P. Kruiswijk · 2021 · Frontiers in Immunology
53. Lipid carriers for mRNA delivery
    Wanting Zhang, Yuxin Jiang, Yonglong He, Hamza Boucetta, Jun Wu, Zhongjian Chen, Wei He · 2022 · Acta Pharmaceutica Sinica B
54. SARS-CoV-2 genomic surveillance in Taiwan revealed novel ORF8-deletion mutant and clade possibly associated with infections in Middle East
    Yu‐Nong Gong, Kuo‐Chien Tsao, Mei–Jen Hsiao, Chung‐Guei Huang, Peng-Nien Huang, Po-Wei Huang, Kuo-Ming Lee, Yi‐Chun Liu, Shu-Li Yang, Rei-Lin Kuo et al. · 2020 · Emerging Microbes & Infections
55. Rationale for targeting complement in COVID‐19
    Anastasia Polycarpou, Mark C. Howard, Conrad A. Farrar, Roseanna Greenlaw, Giorgia Fanelli, Russell Wallis, Linda Sylvia Klavinskis, Steven Howard Sacks · 2020 · EMBO Molecular Medicine
56. Substance Use Disorder in the COVID-19 Pandemic: A Systematic Review of Vulnerabilities and Complications
    Yufeng Wei, Rameen Shah · 2020 · Pharmaceuticals
57. Melatonin potentials against viral infections including COVID-19: Current evidence and new findings
    Kobra Bahrampour Juybari, Mohammad Hossein Pourhanifeh, Azam Hosseinzadeh, Karim Hemati, Saeed Mehrzadi · 2020 · Virus Research
58. Molecular diversity of coronavirus host cell entry receptors
    Jean K. Millet, Javier A. Jaimes, Gary R. Whittaker · 2020 · FEMS Microbiology Reviews
59. COVID-19 and Cancer Comorbidity: Therapeutic Opportunities and Challenges
    Anup Singh Pathania, Philip Prathipati, Bakrudeen AA. Abdul, Srinivas Prabhu Chava, Santharam S. Katta, Subash Chandra Gupta, Pandu R. Gangula, Manoj Kumar Pandey, Donald L. Durden, Siddappa N. Byrareddy et al. · 2020 · Theranostics
60. Recent advances in nanomaterials based biosensors for point of care (PoC) diagnosis of Covid-19 – A minireview
    Gowri Annasamy, N. Ashwin Kumar, Suresh Anand · 2021 · TrAC Trends in Analytical Chemistry
61. An intranasal vaccine durably protects against SARS-CoV-2 variants in mice
    Ahmed O. Hassan, Swathi Shrihari, Matthew J. Gorman, Baoling Ying, Dansu Yuan, Saravanan Raju, Rita E. Chen, Igor P. Dmitriev, Elena A. Kashentseva, Lucas J. Adams et al. · 2021 · Cell Reports
62. Neutralizing antibodies for the prevention and treatment of COVID-19
    L. Du, Yang Yang, Xiujuan Zhang · 2021 · Cellular & Molecular Immunology
63. Beneficial Properties of Bromelain
    Paweł Hikisz, Joanna Bernasinska-Slomczewska · 2021 · Nutrients
64. Perspectives on SARS-CoV-2 Main Protease Inhibitors
    Kaifu Gao, Rui Wang, Jiahui Chen, Jetze J. Tepe, Faqing Huang, Guo‐Wei Wei · 2021 · Journal of Medicinal Chemistry
65. Physicochemical properties of SARS‐CoV‐2 for drug targeting, virus inactivation and attenuation, vaccine formulation and quality control
    Christin Scheller, Finja Krebs, Robert Minkner, Isabel Astner, María Gil‐Moles, Hermann Wätzig · 2020 · Electrophoresis
66. Gastrointestinal involvement in COVID-19: a systematic review and meta-analysis
    Theodore Rokkas · 2020 · Annals of Gastroenterology
67. Protein structure analysis of the interactions between SARS-CoV-2 spike protein and the human ACE2 receptor: from conformational changes to novel neutralizing antibodies
    Ivan Mercurio, Vincenzo Tragni, Francesco Busto, Anna Grassi, Ciro Leonardo Pierri · 2020 · Cellular and Molecular Life Sciences
68. Particulate matter and SARS-CoV-2: A possible model of COVID-19 transmission
    Nguyễn Thanh Tùng, Po-Ching Cheng, Kai Hsien Chi, Ta-Chih Hsiao, Timothy Peter Jones, Kelly BéruBé, Kin‐Fai Ho, Hsiao‐Chi Chuang · 2020 · The Science of The Total Environment
69. In Silico Drug Repurposing for SARS-CoV‑2 Main Proteinase and Spike Proteins
    Irene Maffucci, Alessandro Contini · 2020 · Journal of Proteome Research
70. A platform incorporating trimeric antigens into self-assembling nanoparticles reveals SARS-CoV-2-spike nanoparticles to elicit substantially higher neutralizing responses than spike alone
    Baoshan Zhang, Cara W. Chao, Yaroslav Tsybovsky, Olubukola M. Abiona, Geoffrey B. Hutchinson, Juan I. Moliva, Adam S. Olia, Amarendra Pegu, Emily Phung, Guillaume B. E. Stewart-Jones et al. · 2020 · Scientific Reports
71. Biomechanical characterization of SARS-CoV-2 spike RBD and human ACE2 protein-protein interaction
    Wenpeng Cao, Chuqiao Dong, Seonghan Kim, Decheng Hou, Wanbo Tai, Lanying Du, Wonpil Im, Xiao Hui Zhang · 2021 · Biophysical Journal
72. SARS-CoV-2 viremia is associated with distinct proteomic pathways and predicts COVID-19 outcomes
    Yijia Li, Alexis M. Schneider, Arnav Mehta, Moshe Sade-Feldman, Kyle R. Kays, Matteo Gentili, Nicole C. Charland, Anna L. K. Gonye, Irena Gushterova, Hargun K. Khanna et al. · 2021 · Journal of Clinical Investigation
73. Structure genomics of SARS-CoV-2 and its Omicron variant: drug design templates for COVID-19
    Canrong Wu, Wanchao Yin, Yi Jiang, H. Eric Xu · 2022 · Acta Pharmacologica Sinica
74. A prefusion SARS-CoV-2 spike RNA vaccine is highly immunogenic and prevents lung infection in non-human primates
    Vogel, Annette B., Kanevsky, Isis, Che, Ye, Swanson, Kena A., Muik, Alexander, Vormehr, Mathias, Kranz, Lena M., Walzer, Kerstin C., Hein, Stephanie, Güler, Alptekin et al. · 2020
75. Infection Risk Assessment of COVID-19 through Aerosol Transmission: a Case Study of South China Seafood Market
    Xiaole Zhang, Zheng Ji, Yang Yue, Huan Liu, Jing Wang · 2020 · Environmental Science & Technology
76. Unraveling the Possible Routes of SARS-COV-2 Invasion into the Central Nervous System
    Maria Lima, Vasileios Siokas, Athina‐Maria Aloizou, Ioannis Liampas, Alexios‐Fotios A. Mentis, Zisis Tsouris, Anastasios Papadimitriou, Panayiotis D. Mitsias, Aristidis Michael Tsatsakis, Dimitrios Petrou Bogdanos et al. · 2020 · Current Treatment Options in Neurology
77. Engineered ACE2 receptor therapy overcomes mutational escape of SARS-CoV-2
    Yusuke Higuchi, Tatsuya Suzuki, Takao Arimori, Nariko Ikemura, Emiko Mihara, Yuhei Kirita, Eriko Ohgitani, Osam Mazda, Daisuke Motooka, Shota Nakamura et al. · 2021 · Nature Communications
78. SARS-CoV-2 spike engagement of ACE2 primes S2′ site cleavage and fusion initiation
    Shi Yu, Xu Zheng, Bingjie Zhou, Juan Li, Mengdan Chen, Rong Xin Deng, Gary Wong, Dimitri Lavillette, Guangxun Meng · 2021 · Proceedings of the National Academy of Sciences
79. In-Cell Structural Biology by NMR: The Benefits of the Atomic Scale
    François‐Xavier Theillet · 2022 · Chemical Reviews
80. Repurposing Therapeutics for COVID-19: Supercomputer-Based Docking to the SARS-CoV-2 Viral Spike Protein and Viral Spike Protein-Human ACE2 Interface
    Micholas Dean Smith, Jeremy C. Smith · 2020 · ChemRxiv
81. Amantadine disrupts lysosomal gene expression: A hypothesis for COVID19 treatment
    Sandra Paulina Smieszek, Bartlomiej P. Przychodzen, Mihael H. Polymeropoulos · 2020 · International Journal of Antimicrobial Agents
82. Safety and immunogenicity of CpG 1018 and aluminium hydroxide-adjuvanted SARS-CoV-2 S-2P protein vaccine MVC-COV1901: interim results of a large-scale, double-blind, randomised, placebo-controlled phase 2 trial in Taiwan
    Szu-Min Hsieh, Ming-Che Liu, Yen-Hsu Chen, Wen-Sen Lee, Shinn-Jang Hwang, Shu-Hsing Cheng, Wen-Chien Ko, Kao-Pin Hwang, Ning-Chi Wang, Yu-Lin Lee et al. · 2021 · The Lancet Respiratory Medicine
83. Structural basis and mode of action for two broadly neutralizing antibodies against SARS-CoV-2 emerging variants of concern
    Wenwei Li, Yaozong Chen, Jérémie Prévost, Irfan Ullah, Maolin Lu, Shang Yu Gong, Alexandra Tauzin, Romain Gasser, Dani Vézina, Sai Priya Anand et al. · 2021 · Cell Reports
84. Inferring microenvironmental regulation of gene expression from single-cell RNA sequencing data using scMLnet with an application to COVID-19
    Cheng, Jinyu, Zhang, Ji, Wu, Zhongdao, Sun, Xiaoqiang · 2021 · Briefings in Bioinformatics
85. High Expression of ACE2 on Keratinocytes Reveals Skin as a Potential Target for SARS-CoV-2
    Xiaotong Xue, Zihao Mi, Zhenzhen Wang, Zheng Pang, Hong Liu, Furen Zhang · 2020 · Journal of Investigative Dermatology
86. Contributions of human ACE2 and TMPRSS2 in determining host–pathogen interaction of COVID-19
    Sabyasachi Senapati, Pratibha Banerjee, Sandilya Bhagavatula, Prem Prakash Kushwaha, Shashank Kumar · 2021 · Journal of Genetics
87. Persistent immune imprinting occurs after vaccination with the COVID-19 XBB.1.5 mRNA booster in humans
    M. Alejandra Tortorici, Amin Addetia, Albert J. Seo, Jack T Brown, Kaiti Sprouse, Jenni Logue, Erica Clark, Nicholas Franko, Helen Y. Chu, David Veesler · 2024 · Immunity
88. Comparison of the COVID-2019 (SARS-CoV-2) Pathogenesis With SARS-CoV and MERS-CoV Infections
    Mona Fani, Ali Teimoori, Shokouh Ghafari · 2020 · Future Virology
89. Flavonoids Activation of the Transcription Factor Nrf2 as a Hypothesis Approach for the Prevention and Modulation of SARS-CoV-2 Infection Severity
    Patricia Mendonca, Karam F. A. Soliman · 2020 · Antioxidants
90. Conformational transition of SARS-CoV-2 spike glycoprotein between its closed and open states
    Mert Gür, Elhan Taka, Sema Zeynep Yilmaz, Ceren Kılınç, Umut Aktas, Mert Gölcük · 2020 · The Journal of Chemical Physics
91. Receptor-binding domain-specific human neutralizing monoclonal antibodies against SARS-CoV and SARS-CoV-2
    Fei Yu, Rong Xiang, Xiaoqian Deng, Lili Wang, Zhengsen Yu, Shijun Tian, Ruiying Liang, Yanbai Li, Tianlei Ying, Shibo Jiang · 2020 · Signal Transduction and Targeted Therapy
92. Evidences for lipid involvement in SARS-CoV-2 cytopathogenesis
    Roberta Nardacci, Francesca Colavita, Concetta Castilletti, Daniele Lapa, Giulia Matusali, Silvia Meschi, Franca Del Nonno, Daniele Colombo, Maria Rosaria Capobianchi, Alimuddin I. Zumla et al. · 2021 · Cell Death and Disease
93. The COVID-19 pandemic in the African continent
    Godfrey Bwire, Alex Riolexus Ario, Patricia Eyu, Felix Ocom, Joseph Francis Wamala, Kwadwo Asamoah Kusi, Latif Ndeketa, Kondwani Jambo, Rhoda K. Wanyenze, Ambrose Otau Talisuna · 2022 · BMC Medicine
94. SARS-CoV-2 neutralizing antibody responses are more robust in patients with severe disease
    Wang, Pengfei, Liu, Lihong, Nair, Manoj S., Yin, Michael T., Luo, Yang, Wang, Qian, Yuan, Ting, Mori, Kanako, Solis, Axel Guzman, Yamashita, Masahiro et al. · 2020 · Emerging Microbes & Infections
95. Dengue Fever, COVID ‐19 ( SARS‐CoV ‐2), and Antibody‐Dependent Enhancement ( ADE ): A Perspective
    Henning Ulrich, Micheli Mainardi Pillat, Attila Tárnok · 2020 · Cytometry Part A
96. Implications of antibody-dependent enhancement of infection for SARS-CoV-2 countermeasures
    Nikolai Eroshenko, Taylor Gill, Marianna K. Keaveney, George McDonald Church, José Trevejo, Hannu Rajaniemi · 2020 · Nature Biotechnology
97. Time series prediction of COVID-19 by mutation rate analysis using recurrent neural network-based LSTM model
    Refat Khan Pathan, Munmun Biswas, Mayeen Uddin Khandaker · 2020 · Chaos Solitons & Fractals
98. Considerations for target oxygen saturation in COVID-19 patients: are we under-shooting?
    Niraj Konchady Shenoy, Rebecca A. Luchtel, Perminder Gulani · 2020 · BMC Medicine
99. A panel of human neutralizing mAbs targeting SARS-CoV-2 spike at multiple epitopes
    Tal Noy-Porat, Efi Makdasi, Ron Alcalay, Adva Mechaly, Yinon Levy, Adi Bercovich-Kinori, Ayelet Zauberman, Hadas Tamir, Yfat Yahalom-Ronen, Ma’ayan Israeli et al. · 2020 · Nature Communications
100. Coronavirus Resistance Database (CoV-RDB): SARS-CoV-2 susceptibility to monoclonal antibodies, convalescent plasma, and plasma from vaccinated persons
     Philip L. Tzou, Kaiming Tao, Sergei L. Kosakovsky Pond, Robert W. Shafer · 2022 · PLoS ONE